临床试验/NCT04857801

NCT04857801已完成不适用

Teduglutide in Short Bowel Syndrome Patients - A Way Back to Normal Life?

Medical University of Vienna0 个研究点目标入组 17 人开始时间: 2016年6月1日最近更新: 2021年4月26日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Medical University of Vienna
入组人数: 17
主要终点: enteral autonomy

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

•< 18 years
•Incompliance
•< 6 months of treatment

结局指标

主要结局

enteral autonomy

时间窗: at least 6 months of teduglutide treatment

percentage of patients reaching complete discontinuation of parenteral support

次要结局

未报告次要终点

研究者

发起方

Medical University of Vienna

申办方类型

Other

责任方

Principal Investigator

主要研究者

Felix Harpain

Principle Investigator

Medical University of Vienna

相似试验

已完成

3 期

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionShort Bowel Syndrome

NCT02682381Shire59

已完成

4 期

Short Bowel Syndrome and Teduglutide Versus PlaceboShort Bowel Syndrome

NCT02099084Mayo Clinic8

进行中（未招募）

不适用

Treatment of Short Bowel Syndrome Patients with end-jejunostomi with the Glucagon-Like Peptide-1 analogue, Liraglutide (Victoza®)Short Bowel Syndrome with intestinal failure (SBS IF)MedDRA version: 16.1Level: LLTClassification code 10022683Term: Intestinal malabsorptionSystem Organ Class: 100000004856MedDRA version: 16.1Level: LLTClassification code 10036430Term: Post surgical malabsorption NOSSystem Organ Class: 100000004856MedDRA version: 16.1Level: LLTClassification code 10042822Term: Syndrome malabsorptionSystem Organ Class: 100000004856

EUCTR2013-005499-16-DKRigshospitalet, 2121

进行中（未招募）

1 期

Pilot Study with Treatment of Short Bowel Syndrome Patients with dipeptidyl-peptidase 4 inhibitor, Sitagliptin (Januvia®)Short Bowel Syndrome with intestinal failure (SBS IF)MedDRA version: 17.1 Level: LLT Classification code 10022683 Term: Intestinal malabsorption System Organ Class: 100000004856MedDRA version: 17.1 Level: LLT Classification code 10036430 Term: Post surgical malabsorption NOS System Organ Class: 100000004856MedDRA version: 17.1 Level: LLT Classification code 10042822 Term: Syndrome malabsorption System Organ Class: 100000004856

EUCTR2014-001941-25-DKRigshospitalet 212110

招募中

不适用

Fiber Food Introduction in Pediatric Short Bowel SyndromeShort Gut Syndrome

NCT05432648Children's Hospital of Philadelphia60